PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Service de pharmacologie clinique, Département de médecine de laboratoire et de pathologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.\', \'Policlinique de médecine tropicale, voyages et vaccination, Unisanté - Centre universitaire de médecine générale et santé publique, 1011 Lausanne.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.53738/REVMED.2022.18.767.190
?:doi
?:hasPublicationType
?:journal
  • Revue medicale suisse
is ?:pmid of
?:pmid
?:pmid
  • 35107895
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.128
?:rankingScore_hIndex
  • 14
?:title
  • [Pharmacovigilance - mRNA COVID-19 vaccines : current state of knowledge on their adverse effects].
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35107895>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35107895>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all